Oxford Coronavirus Vaccine Update: Phase III Trials To Conclude By November, Mass Production Expected By 2021
Oxford Coronavirus Vaccine Update: The University of Oxford-AstraZeneca backed novel coronavirus...
Read MoreOxford Coronavirus Vaccine Update: The University of Oxford-AstraZeneca backed novel coronavirus...
Read MoreRussia’s coronavirus vaccine: An announcement by Russia on Tuesday that it will approve a...
Read MoreRussian President Vladimir Putin on Tuesday launched the country’s first COVID-19 vaccine, touted...
Read MoreRegistration for the world’s first coronavirus vaccine: In what can be called the biggest...
Read MoreAhmedabad-based Zydus Cadila’s ZyCoV-D COVID vaccine, targeted to hit markets by early next...
Read MoreModerna Inc.’s vaccine candidate against Covid-19 protected against the virus in a trial that...
Read MoreOxford COVID Vaccine: In a recent development regarding the Oxford Vaccine phase 3 trials, Renu...
Read MoreRussia Vaccine: A Covid-19 vaccine developed with the Russian Defense Ministry completed Phase 2...
Read MoreOxford vaccine: The human trial of the COVID-19 vaccine candidate developed by the University of...
Read MoreHuman dosing of Bharat Biotech International Ltd’s vaccine candidate ‘covaxin’ against the novel...
Read More